REQUEST A DEMO
Total
USD $0.00
Search more companies

Golden Biotechnology Corp. (国鼎生物科技股份有限公司) (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Golden Biotechnology Corp. Profile Updated: January 28, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Golden Biotechnology Corp. (国鼎生物科技股份有限公司) is a company based in Taiwan, China, with its head office in Taipei City. The company operates in the Pharmaceutical and Medicine Manufacturing industry. Golden Biotechnology Corp. (国鼎生物科技股份有限公司) was incorporated on September 27, 2002. It currently has a total number of 103 (2023) employees. There was a net sales revenue increase of 15.96% reported in Golden Biotechnology Corp. (国鼎生物科技股份有限公司)’s latest financial highlights for Q2C2025. During that time, Golden Biotechnology Corp. (国鼎生物科技股份有限公司)’s total assets decreased by 5.41%. In 2025, Golden Biotechnology Corp. (国鼎生物科技股份有限公司)’s net profit margin increased by 268.37%.

Headquarters
15Th Fl., No.27-6, Sec.2,Chung Cheng East Rd., Tamsui Town
Taipei City; Taipei City;

Contact Details: Purchase the Golden Biotechnology Corp. (国鼎生物科技股份有限公司) report to view the information.

Website: http://www.goldenbiotech.com.tw

Basic Information
Total Employees:
Purchase the Golden Biotechnology Corp. (国鼎生物科技股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Golden Biotechnology Corp. (国鼎生物科技股份有限公司) report to view the information.
Financial Auditors:
Purchase the Golden Biotechnology Corp. (国鼎生物科技股份有限公司) report to view the information.
Incorporation Date:
September 27, 2002
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
3.42%
Purchase this report to view the information.
3.41%
Purchase this report to view the information.
2.92%
Purchase this report to view the information.
2.18%
Purchase this report to view the information.
1.73%
Subsidiaries
Golden Biotechnology Corp. (De) (United States)
100%
Goldenbiotech Nology Japan (Japan)
100%
Pt Royal Golden Biotechnology (Indonesia)
99.98%
Company Performance
Financial values in the chart are available after Golden Biotechnology Corp. (国鼎生物科技股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
15.96%
Total Operating Revenue
16.73%
Operating Profit
32.82%
EBITDA
37.44%
Net Profit/Loss for the Period
28.46%
Total Assets
-5.41%
Total Equity
-20.86%
Operating Profit Margin
295.2%
Net Profit Margin
268.37%
Return on Equity (ROE)
6.42%
Debt / Equity
45745%
Quick Ratio
-68.88%
Cash Ratio
-0.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?